Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human
health and scientific research. Empowering researchers to perform single cell sequencing with
unprecedented scale and ease, our pioneering approach is enabling groundbreaking discoveries in
cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and
the immune system.
Founded based on a transformative technology invented at the University of Washington, Parse is
used by over 1,000 labs across the world. Our growing portfolio of products includes Evercode Whole
Transcriptome, Evercode TCR, Gene Capture, and a software tool for data analysis.
Headquartered in Seattle, Washington's vibrant South Lake Union district, Parse Biosciences recently opened a 34,000 square foot headquarters and state-of-the-art laboratory.